Fortrea Holdings Inc. (NASDAQ: FTRE) is a Healthcare company (Biotechnology) with a market capitalization of $1.9B. The Maz Rating grades it against the other companies in its sector.
Fortrea Holdings Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $19.59, Fortrea Holdings Inc. trades at 0.7x sales and 3.5x book value, with an EV/EBITDA of 26.4. Over the last twelve months it generated about $2.7B of revenue and a net loss of $71M. It runs a gross margin of 18.5%, an operating margin of 1.6% and a net margin of -2.6%. It shows return on equity of -12.8%, return on invested capital of 2.3% and a free cash flow yield of 6.7%. On the balance sheet: a debt-to-equity ratio of 2.10 and a current ratio of 0.97. Over the past 52 weeks the share price ranged from $8.55 to $26.16, with a beta of 1.86.
Fortrea Holdings Inc. does not currently pay a dividend.
13 Wall Street analyst ratings cover the stock: 7 Buy, 5 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.